abstract: Hydatidiform mole (HM) is a human pregnancy with abnormal embryonic development. NLRP7 is a major autosomal recessive gene responsible for recurrent molar pregnancies and associated reproductive wastage in patients from several populations. Here, we report NLRP7 mutation analysis in 35 unrelated Chinese patients with recurrent reproductive wastage, including at least one HM. We describe three new protein-truncating mutations in NLRP7 and show the presence of three founder mutations in China and Asian populations. We determined the parental contribution to six molar tissues and show the occurrence of three diploid androgenetic moles in patients with one defective allele, while three diploid biparental moles occurred in patients with two defective alleles. We document the failure of pregnancies after assisted reproductive technologies (ARTs) in three patients with two defective alleles each and a successful pregnancy in one of two patients with one defective allele. Our data suggest that patients with a single defective allele have better reproductive outcomes than patients with two defective alleles, and some of them may benefit from ART.
Introduction
A hydatidiform mole (HM) (OMIM 231090) is a human pregnancy with no embryo, cystic degeneration of chorionic villi and abnormal proliferation of the trophoblast. The common form of this condition occurs once in every 1000-1500 pregnancies in Western countries, but at higher frequencies in several underdeveloped and developing countries (Bracken et al., 1984) . In China, the reported incidences of HMs vary from 1 to 8.83 in every 1000 pregnancies, with the highest incidence being in the province of Zhejiang (Bracken et al., 1984) . Although the common form of this disorder is sporadic, 1-6% of patients with a prior mole will have a second mole, and 10-20% will have a second non-molar reproductive wastage, most commonly a spontaneous abortion (Van Thiel et al., 1970; Berkowitz et al., 1998; Kim et al., 1998; Lan et al., 2001; Sebire et al., 2003) . This indicates a genetic susceptibility of these women for reproductive wastage. The familial form of this condition, known as familial recurrent HMs (FRHMs), is rare but its exact frequency is not known.
The diagnosis of moles is made based on a histopathological examination, which allows the classification of moles as complete HM (CHM) or partial HM (PHM) based on the degree of trophoblast proliferation and the presence or absence of fetal tissues. At the genotype level, most PHMs are triploid with one maternal and two different paternal sets of chromosomes resulting from dispermic fertilization. Most CHMs are androgenetic, containing two sets of paternal chromosomes. The paternal contribution may be monospermic ( 80% of moles) or dispermic (20%). In rare cases, CHMs are diploid, with both a maternal and a paternal chromosome complement (BiCHM). These BiCHMs are usually associated with an autosomal recessive condition, in which affected women have recurrent moles (FRHM) . Linkage analysis in affected families initially localized a gene for FRHM to 19q13.4 (Moglabey et al., 1999) . Refinement of the region using homozygosity mapping (Hodges et al., 2003) and subsequent screening of candidate genes in the region led to the identification of the maternal gene, NLRP7, as responsible for recurrent moles and reproductive wastage such as spontaneous abortions and stillbirths (Murdoch et al., 2006) . NLRP7 (NLR family, pyrin domain containing 7) belongs to a family of proteins that play roles in inflammation and apoptosis. Also, over expressing NLRP7 in an in vitro cellular model has been shown to inhibit caspase-1-dependent interleukin 1b secretion (Kinoshita et al., 2005) . Furthermore, the expression patterns of NLRP7 in human embryos suggest its importance for normal preimplantation development (Zhang et al., 2008) , and these data are in line with the fact that some patients with NLRP7 mutations have abnormal postzygotic development in vivo and in vitro (Deveault et al., 2009) .
For patients with two moles, the quoted risk for a third mole is 10223% (Berkowitz et al., 1998; Sebire et al., 2003) . However, management options for women with recurrent consecutive molar pregnancies are limited-in particular, for those who strongly desire to conceive their own biological offspring. These options range from no intervention to the use of assisted reproductive technologies (ARTs) such as ICSI, with or without PGD. Some patients with RHM have attempted ICSI and PGD to fulfill their desire of having their own children. To date, there has been only one report of success using IVF to prevent recurrent molar pregnancies (Ogilvie et al., 2009) , and more data are required to confirm its general applications and benefits for women with recurrent moles.
In this study, we report NLRP7 mutation analysis in 35 unrelated Chinese patients with recurrent reproductive wastage, including at least one HM. We identified three new protein-truncating mutations in NLRP7 and demonstrate the presence of founder effects for three mutations in Asian populations. We also report the use of ART in five of these patients and the results of their conceptions.
Materials and Methods

Patients
A total of 35 unrelated Chinese patients with recurrent reproductive wastage, including at least 1 HM and their families were ascertained. Their reproductive and medical histories are shown in Table I (Qian et al., 2007; Deveault et al., 2009 29, 492, 517, 529, 765, 781 and 789 and their partners. All karyotypes were normal, except for two patients: 492 and 768, one with a Robertsonian translocation 45XX,rob(13;14)(q10;q10) and another with a reciprocal translocation 46,XX,t(1;13)(q32;q34), respectively. Five patients described in this study sought the use of ART. Patients 29, 492, 765 and 781 used their own oocytes, while patient 517 used donated oocytes. Semen analyses were performed for the partners of patients 29, 492, 765 and 781, and all met normal criteria. Also, fluorescence in situ hybridization was conducted using a probe for chromosome 8 on a total of 200 sperm nuclei from each partner and revealed the absence of diploid cells.
NLRP7 mutation analysis
Mutation analysis was performed by PCR amplification of genomic DNA of the 11 NLRP7 exons followed by direct sequencing in both directions as previously described (Qian et al., 2007) . In patient 781 with a homozygous deletion spanning exon 6, the previously described primers to amplify exon 6 did not amplify any PCR product. Additional primers were designed and used to amplify and sequence its flanking sequences: Ex6delfwd:
All sequences were analyzed using DNASTAR. DNA mutations are numbered according to the reference sequence NM_206828.2, with nucleotide 1 being the A of the ATG translation initiation site. Protein numbering is according to the reference sequence Q8WX94, beginning with the initiation codon. Our controls are women of Chinese origin from families with at least one child and no abnormal reproductive history.
Results
Identification of three new protein-truncating mutations in NLRP7
Mutation analysis revealed the presence of four previously reported mutations and three new mutations summarized in Table I . The three new mutations are c.2468T . A, p.Leu823X (L823X), in patient 765; a 76 bp deletion in exon 4 that is predicted to lead to a frameshift and protein truncation, 1625_1700del76, p.Met542ThrfsX1 (M542fs), in patient 791; and a 1218 bp deletion spanning exon 6, c.2130-312_2300 + 737del1218, in patient 781. No RNA was available from this patient to investigate the consequences of this deletion on the protein, but the omission of exon 6 from the spliced RNA is predicted to result in a frameshift and protein truncation because exons 5 and 7 are not in frame. Of the 35 analyzed patients, 7 were found to have two mutated alleles (20%), 4 (11.4%) had one mutated allele each and 24 (68.6%) did not have any mutation in NLRP7 (Table I and Supplementary data,  Table SI ). Where additional family members were available for typing, we analyzed the segregation of the mutations within those families ( Fig. 1 ). Of note is the presence of p.Lys379Asn (K379N) in a heterozygous state in patient 774, her mother and sister, both of whom had had two spontaneous abortions each, while the patient had had one HM and one spontaneous abortion. Patient 293 with two previously reported mutations, p.Arg432X (R432X) and p.Ala719Val (A719V), has also another variant, c.2573T . C, p.Ile858Thr (I858T), that was inherited from her mother on the same haplotype carrying A719V (Fig. 1) . We also checked for the presence of the two identified missense mutations, A719V and I858T in 50 Chinese control women (each with at least one child) from the general population and did not find them in any control. In addition, A719V was not found in 100 European women (with 5-15 children) [40 women from the centre d'etude du polymorphisme humain families (Utah, USA) and 60 women of French Canadian origin from families with various genetic disorders unrelated to pregnancy losses] (Slim et al., 2011) . The fact that R432X and A719V were previously reported in other patients indicates that they are probably disease-causing, while I858T could be either a second mutation or a rare variant on the same haplotype carrying A719V. Indicates tissues for which the parental contribution to the moles is provided in the Supplementary materials.
Founder effects for three NLRP7 mutations in China
Among the 12 NLRP7 mutations found in our patients, three were each found in two unrelated Chinese families of Han origin (Table I) . K379N was found in MoCh73 and MoCh193; R432X in Ch77 and MoCh293; and L825X in Ch77 and MoCh200. To investigate the possibility of a founder effect for these mutations, haplotypes were established by genotyping homozygous patients and additional family members of heterozygous patients at 42 single nucleotide polymorphisms within, and in the proximity of, NLRP7. This analysis revealed the presence of identical mutations on haplotypes common to both carriers indicating their inheritance from common ancestors (Table II) . Interestingly, one of these founder mutations, L825X, was previously identified by our group and by another group in two patients from Pakistan (Murdoch et al., 2006; Kou et al., 2008) . We therefore analyzed the haplotype carrying L825X in our Pakistani patient (MoPa61 -443) and found that she shares the same haplotype with the Chinese patient, thus indicating a founder effect for this mutation in Asian populations (Table II) .
Correlation between NLRP7 mutations, molar genotype and ART outcomes
To determine the parental contribution to the moles, available molar tissues from patients 29, 101 and 765 were genotyped along with parental DNAs. The results of this analysis and of previously genotyped molar tissues from all the Chinese patients with NLRP7 mutations are recapitulated in Table I and Supplementary data,  Tables SI -IV. Of the analyzed tissues, three moles were found to be biparental and three were androgenetic. Interestingly, the three biparental moles occurred in women with two NLRP7 mutations, whereas the three androgenetic moles occurred in two patients, each with a single identified defective allele (Table I) . Among the patients with NLRP7 mutations included in this study, five underwent IVF. None of the three women carrying two NLRP7 defective alleles successfully achieved pregnancy despite the fact that these women received a total of 11 embryos. However, of the four embryos transferred to two women who each has a single defective allele, one embryo implanted and the patient is now pregnant (24w) and her pregnancy is normal to date (Table III) .
Discussion
To date, 43 different mutations in NLRP7 have been reported by different groups in women with RHMs and reproductive wastage from various populations demonstrating that NLRP7 is a major cause for this condition (Murdoch et al., 2006; Qian et al., 2007; Kou et al., 2008; Deveault et al., 2009; Hayward et al., 2009; Puechberty et The reproductive outcomes are listed by chronological order from left to right. CHM stands for complete hydatidiform mole; HM is used when no histopathological data or tissues were available to review the diagnosis; AnCHM, androgenetic complete HM; SA, spontaneous abortion; ET indicates elective termination of pregnancy; ¼ indicates that the mutation is found in a heterozygous state and the other allele is normal. Gray circles indicate women with unknown phenotype since they have not tried to conceive. Arrows indicate probands.
The genetics of RHMs in China Muhlstein et al., 2011; INFEVERS: an online database for autoinflammatory mutations). In this study, we sequenced NLRP7 in a total of 35 unrelated Chinese patients and found mutations in only 11 of them (31.4%). Of these 11 patients, 4 have one defective allele and 7 have two defective alleles. Among the latter, only two patients were found homozygous for their mutations.
When only patients with at least two HMs are considered, 11 of 23 (48%) were found to have at least one NLRP7 mutation. Comparing these data with those of Pakistani (11 unrelated patients) (Hayward et al., 2009) and Indian patients (13 unrelated patients) (Slim et al., 2009) with at least 2 HMs revealed two distinctive features of the Chinese population. First, NLRP7 is not a major gene for RHM and reproductive wastage in China since only 48% of Chinese patients with at least 2 HMs have NLRP7 mutations when compared with 81 and 84% of Pakistani and Indian patients, respectively. The absence of NLRP7 mutations does not exclude the presence of unidentified mutations in the promoter and intronic regions, or the presence of large deletions, duplications and rearrangements that cannot be detected by conventional DNA sequencing. However, the fact that the same PCR primers and conditions used in this study were also used by our group to analyze Indian patients indicates that the genetic causes of recurrent moles are not the same in China, Pakistan and India. Another particularity of the Chinese population seems to be a lower rate of consanguinity in China than in Pakistan and India since only 20% of our Chinese patients with at least 2 HMs have homozygous mutations when compared with 88% among Pakistani and 72% among Indian patients. Our data on this selected number of patients are in agreement with the low reported rates of consanguinity in the Chinese population (http://www.consang.net/).
We previously suggested that females carrying one mutated NLRP7 allele are predisposed to pregnancy loss (Qian et al., 2007) . This conclusion was based on the occurrence of stillbirths and spontaneous abortions in heterozygous mothers and sisters of women who have had recurrent biparental hydatidiform moles. This was refuted by Hayward et al. (2009) and Williams et al. (2010) since there was no reproductive wastage in heterozygous relatives of their patients. In this study, we show a previously reported mutation, K379N, in a new patient with one mole while her mother and sister who carry the same mutation had had two spontaneous abortions each, with other normal pregnancies (Fig. 1) . These results suggest that some, but not all, NLRP7 mutations are associated with reproductive wastage when present in a heterozygous state. This also indicates that mild genetic defects due to one defective allele may be modulated by environmental and other genetic factors and consequently are not associated with moles in every patient and do not impede all of their pregnancies.
Founder effects for two NLRP7 mutations have been demonstrated in the Indian population based on haplotype analysis (Slim et al., 2009) and in several other populations based on the presence of identical mutations in patients from the same ethnicity (Kou et al., 2008) . In agreement with, these data are the presence of founder effects for three Chinese mutations-K379N, R432X and L825X, with the latter being common to the Pakistani and Chinese populations. The identification of founder mutations in Asian populations is interesting because these populations are known to have higher incidences of moles than European populations.
It has already been reported that in patients with many RHMs, the moles tend to be biparental in origin and most of these patients have two defective NLRP7 alleles (Fisher et al., 2004) . To date, beside the Chinese patients reported or recapitulated in this study, only one other patient with an androgenetic mole has been reported and in this patient, one NLRP7 mutation had been identified (Deveault et al., 2009) . In addition, two other patients each with one mutated NLRP7 allele were also found to have triploid and diandric moles (Slim et al., 2011) . In support of these observations is our finding that the three biparental moles occurred in patients with two defective NLRP7 alleles (patients 29, 101 and 519) while the three androgenetic moles occurred in two patients (492 and 765) with one defective allele, each. In addition, there have not been any reports, to date, of patients carrying two defective NLRP7 mutations who had had androgenetic moles. Altogether, these data indicate an association between NLRP7 mutation status and molar genotypes in which two defective alleles are associated with biparental moles, while a single defective allele is associated with diploid androgenetic and triploid moles. Characterizing more molar tissues from patients with one or two NLRP7 defective alleles will be helpful to validate our observations in a larger cohort of patients.
We previously reported early embryo cleavage abnormalities during in vivo and in vitro development of embryos from two patients with one NLRP7 mutation each. We proposed that these cleavage abnormalities may depend on the nature of the mutations (Deveault et al., 2009) . In this study, only one of the five patients had postzygotic abnormalities after IVF and this is the same patient in which we previously reported The genetics of RHMs in China postzygotic cleavage abnormalities after ICSI (Deveault et al., 2009 ). None of the three patients with two defective alleles, reported in this study, achieved a successful pregnancy after ART, while one of the two patients with one defective allele in currently 5 months pregnant and her pregnancy is going well. Also, the data reported in this study indicate first that not all patients with NLRP7 mutations have postzygotic abnormalities, and second that patients with one mutated NLRP7 allele seem to have better reproductive outcomes than patients with two mutated alleles and have higher chances of having normal pregnancies. These observations are in agreement with the association of two NLRP7 mutations with highly recurrent biparental moles and low chances of successful pregnancies, while one mutated allele is associated with androgenetic or triploid moles, less recurrent moles and more live births. These data are also in line with a recent report by Ogilvie et al. documenting the successful use of ICSI and preimplantation genotyping in a patient with recurrent androgenetic complete moles (Ogilvie et al., 2009) . Again, validating our observations in a larger cohort of patients will help reaching conclusive results about management options for patients with recurrent moles and one or two NLRP7 mutations. Among the 35 analyzed patients, two 492 and 768 had abnormal karyotypes 45,XX,rob(13;14)(q10;q10) and 46,XX,t(1;13)(q32;q34), respectively. While the latter did not have any mutation in NLRP7, the former is heterozygous for one mutation. Among previously reported patients with recurrent moles and NLRP7 mutations, one patient homozygous for mutation R693W and carrying an abnormal karyotype 46,XXinv(14)(q21q23-31) has been reported (Puechberty et al., 2009) . Although, some of these chromosomal abnormalities are present in the general population and in women with normal pregnancies, their presence in the small number of reported patients with recurrent moles and the fact that they all involve acrocentric chromosomes is intriguing. Also, such chromosomal abnormalities may, in addition to the mutations, have some additive effects and contribute to the recurrent reproductive losses in these patients. Analyzing the karyotype of the parents of these patients will be important to determine whether these mutations are inherited in their respective families or whether they occurred de novo.
